Governance

Governance Policies
GXH Company Constitution 30 July 2019
GXH Board Charter March 2021
GXH Audit & Risk Committee Charter March 2021
GXH Nominations Committee Charter March 2021
GXH Remuneration Committee Charter March 2021
GXH Investment Committee Charter March 2021
GXH Securities Trading policy March 2021
GXH Code of Ethics Policy March 2021
GXH Continuous Disclosure Policy March 2021
GXH Diversity Policy March 2021
GXH Remuneration Policy March 2021
GXH Protected Disclosure Policy March 2021


Board of Directors
Kim Ellis
Chair

Kim Ellis is a widely experienced Chief Executive best known for his 13 years at the helm of Waste Management NZ Ltd, culminating in the company’s sale in 2006. During his tenure he led 40 acquisitions and built a successful business in Australia.

Kim’s earlier career encompassed a number of market sectors including health, manufacturing, distribution, transport, property, agriculture and fashion. Since 2006 Kim has been active in governance. Kim is currently Chair of NZ Social Infrastructure Fund; a Director of Freightways, Port of Tauranga, FSF Management Company and Ballance Agri-Nutrients; and consultant to Envirowaste Services.

Kim holds first class honours degrees in Chemical Engineering and Economics.

Peter Merton
Non-Executive Director

Peter Merton, an Otago University Pharmacy graduate, has been involved in the pharmaceutical industry in New Zealand and overseas since the early 1980s.
His involvement with the company goes back to the late 1990s, and he played an active part in the initial industry consolidation when Amcal and Unichem brands merged to form Pharmacybrands Limited, later renamed Green Cross Health Limited.

Following the merger of Life Pharmacy Limited (LPL) with Pharmacybrands Limited in 2009 Peter assumed the role of Chair of the Group. He is also a significant shareholder in the company through his interest in Cape Healthcare Limited. Peter has previously held the roles of Chief Executive of the Propharma/Healthcare Logistics businesses and Director of EBOS Group Limited.

Andrew Bagnall
Non-Executive Director

Andrew Bagnall holds a Commerce Degree from Otago University and a MBA from Michigan State University. Andrew was a significant investor in Life Pharmacy Limited and following the merger with Pharmacybrands Limited (later renamed Green Cross Health Limited) has continued to hold a significant shareholding in the merged entity.

In Andrew’s earlier career, he was a leading figure in the New Zealand travel industry establishing and managing Gullivers Travel Group which became the major distributor of wholesale and retail travel services in New Zealand. Gullivers Travel Group was eventually listed on the New Zealand and Australian stock exchanges (ASX) and was subsequently sold to ASX listed S8. Andrew was also involved in co-developing one of New Zealand’s first commercial retirement villages. Andrew now runs his own private investment company, Segoura, which manages investments in various businesses and he maintains a keen interest in sports car racing.

Andrew was appointed as a Non-Executive Director of the Company in August 2009.

John Bolland
Non-Executive Director

John Bolland has more than 25 years experience in private equity, senior management and corporate finance. This includes 14 years with Ernst & Young, where he had Partner level responsibility in Corporate Finance and Audit & Business Advisory. John holds a Bachelor of Commerce from the University of Auckland and is a Member of the New Zealand Institute of Chartered Accountants.

John was appointed as a Non-Executive Director of the Company in August 2009.

Peter Williams
Non-Executive Director

Peter Williams was appointed a director of Green Cross Health in May 2017.

Peter is also a director of EBOS Group Ltd. Peter has over 20 years experience in healthcare being formerly an executive of The Zuellig Group which has extensive healthcare interests in Asia Pacific.

Ken Orr
Independent Director

Ken Orr has had over 30 years as a community pharmacist and is currently a partner in a group of pharmacies in Northland. Ken was a former President of the NZ Pharmacy Guild, which represents the business interests of community pharmacies. Ken was a forming director of Manaia PHO and now serves on the Audit, Risk & Finance committee of Mahitahi Hauora that leads primary health care in Northland.

Ken joined the Board in September 2009 as an alternate Director and was appointed as an Independent Director of the Company in March 2012.

Carolyn Steele
Independent Director

Carolyn Steele is a director of WEL Networks Limited, Ultrafast Fibre Limited, Oriens Capital GP 2 Limited, Vulcan Steel Limited and chair of The Halberg Foundation. Until 2016, Carolyn was a Portfolio Manager at Guardians of New Zealand Superannuation, the Crown entity managing the New Zealand Superannuation Fund. Prior to joining the Guardians in 2010, Carolyn spent ten years in investment banking at Forsyth Barr and Credit Suisse/First NZ Capital.

Carolyn was appointed as an Independent Director of the Company in June 2017.